Stable nonsegmental and segmental vitiligo lesions (for the last 3 months) Vitiligo,
Conditions
Interventions
0.01% bimatoprost ophthalmic solution (Lumigan) applied lesion bid,Combination of 0.01% bimatoprost ophthalmic solution (Lumigan) and targeted NB-
UVB twice a week,Placebo (normal saline) applied lesion bid
0.01% bimatoprost ophthalmic solution (Lumigan),Combination of .01% bimatoprost ophthalmic solution (Lumigan®) and targeted NB-
UVB,Placebo (normal saline)
Sponsors
Department of dermatology, Siriraj Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Stable nonsegmental and segmental vitiligo lesions (for the last 3 months) 2. Without received any local treatment for vitiligo for at least 2 weeks before the study 3. Without received any photo therapy for vitiligo for at least 4 weeks before the study
Exclusion criteria
Exclusion criteria: 1. Photosensitive patients, those with light aggravated dermatoses 2. Pregnant 3. Lactating females and patients with asthma or hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of bimatoprost in the treatment of vitiligo 8 months Photographs, VASI Score, Extent of repigmentation,Efficacy of bimatoprost combined with targeted NB-UVB in the treatment of vitiligo 8 months Photographs, VASI Score, Extent of repigmentation | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of bimatoprost in the treatment of vitiligo 8 months Patients' evaluation | — |
Countries
Thailand
Contacts
Public ContactNarumol Silpa-archa
Department of dermatology, Siriraj Hospital
Outcome results
None listed